Of interest, a significant induction of DNA damage response for the drug combination in comparison to cisplatin was observed in two of the three investigated DLBCL cell lines, suggesting that Hsp90 inhibition by 17AAG, leads to an impairment in DNA repair after DNA damage. This evidence concerns the gene HSP90AB1 and diffuse large B-cell lymphoma.